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Abstract
Background and Aims: Cognitive behavioral group therapy (CBGT) is an effective, well-established, but not widely available
treatment for social anxiety disorder (SAD). Internet-based cognitive behavior therapy (ICBT) has the potential to increase
availability and facilitate dissemination of therapeutic services for SAD. However, ICBT for SAD has not been directly
compared with in-person treatments such as CBGT and few studies investigating ICBT have been conducted in clinical
settings. Our aim was to investigate if ICBT is at least as effective as CBGT for SAD when treatments are delivered in a
psychiatric setting.
Methods: We conducted a randomized controlled non-inferiority trial with allocation to ICBT (n=64) or CBGT (n=62) with
blinded assessment immediately following treatment and six months post-treatment. Participants were 126 individuals with
SAD who received CBGT or ICBT for a duration of 15 weeks. The Liebowitz Social Anxiety Scale (LSAS) was the main outcome
measure. The following non-inferiority margin was set: following treatment, the lower bound of the 95 % confidence
interval (CI) of the mean difference between groups should be less than 10 LSAS-points.
Results: Both groups made large improvements. At follow-up, 41 (64%) participants in the ICBT group were classified as
responders (95% CI, 52%–76%). In the CBGT group, 28 participants (45%) responded to the treatment (95% CI, 33%–58%).
At post-treatment and follow-up respectively, the 95 % CI of the LSAS mean difference was 0.68–17.66 (Cohen’s d between
group=0.41) and 22.51–15.69 (Cohen’s d between group=0.36) favoring ICBT, which was well within the non-inferiority
margin. Mixed effects models analyses showed no significant interaction effect for LSAS, indicating similar improvement
across treatments (F=1.58; df=2, 219; p=.21).
Conclusions: ICBT delivered in a psychiatric setting can be as effective as CBGT in the treatment of SAD and could be used
to increase availability to CBT.
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Introduction
Social anxiety disorder (SAD), or social phobia, is characterized
by a persistent and debilitating fear of being evaluated by others.
SAD typically has an early onset [1], runs a chronic course [2], is
one of the most prevalent anxiety disorder in the western world
[3], and is associated with functional impairment [4]. Cognitive
behavioral group therapy (CBGT) for SAD has proven to be
effective in several randomized controlled trials (RCTs) over the
last 20 years. Results have shown that CBGT is superior to
psychological [5] and pill placebo and that it can be as effective as
pharmacological treatment with SSRIs [6], making it the most
established psychological treatment for SAD [7,8]. However,
CBGT is available to only a few due to a lack of trained therapists
[9]. While individually administered CBT has demonstrated large
effects [10] and might be more efficacious than CBGT [11,12],
this treatment format is even more dependent on the availability of
trained therapists.
More recently, guided Internet-based CBT (ICBT) has shown
promising results in RCTs conducted by three independent
research groups [13,14,15,16,17,18]. The treatment entails the
same components as conventional CBT, such as exposure to
feared situations, but is delivered over the Internet with therapist
contact via an online messaging system resembling e-mail [14].
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e18001Evidence has shown that improvements made during ICBT are
persistent [19]. ICBT has some important advantages over live
treatment. First, it is not restricted in time or to a specific
geographic location (i.e., patients as well as therapists can work
with the treatment at any time or place they wish). Second, since
ICBT demands less therapist time, ICBT therapists can treat
significantly more patients than possible with CBGT [20,21].
Consequently, ICBT has the potential to dramatically increase
availability of CBT.
Although ICBT for SAD has demonstrated effects in line with
CBGT, the current evidence holds a number of limitations. There
has been no comparison to conventional CBT, such as CBGT,
and most studies have relied solely on self-report instruments as
measures of treatment outcome. In addition, most studies have
been conducted in university settings, which might have a different
impact on treatment experience and outcome compared to
receiving care at a psychiatric clinic. Although one study has
indicated that the characteristics of Internet clinic patients could
be similar to those of outpatient clinics [22], the research field
would benefit from a trial conducted in a psychiatric context.
Finally, diagnostic procedures may be more clinically valid when
conducted in a clinical setting. This has not been the case in the
previous studies where only telephone interviews or self-report
have been used.
In summary, more empirical evidence is needed before ICBT
can be validly employed in a psychiatric context. As CBGT is an
effective gold standard treatment appropriate for use as a
benchmark [23], the necessary evidence to validate ICBT is to
demonstrate non-inferiority (i.e., equal efficacy) to CBGT [24].
The aim of the present study was to determine whether ICBT is as
effective as CBGT for patients with SAD when administered in a
psychiatric setting. We hypothesized that ICBT would be at least
as effective as CBGT in reducing social anxiety. We also predicted
that the two treatments would be equal on secondary outcome
measures of depressive symptoms, general anxiety, quality of life,
and global functioning.
Methods
Trial design
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1. This was a non-inferiority trial within the context of a
parallel group study with unrestricted randomisation in 1:1 ratio
conducted in Sweden. Outcome assessors were blind to treatment
status.
Recruitment and selection
Recruitment for the study took place between 2007 and 2009.
Participants were recruited by referral from primary care
physicians and psychiatrists, and by self-referral to the psychiatric
clinic at the Karolinska University Hospital in Stockholm, Sweden.
Informationabout the treatmentand thestudywaspublished onthe
official webpageoftheclinic(www.internetpsykiatri.se). Therewere
no advertisements in newspapers or other media. The study
protocol was approved by the Regional Ethical Review Board in
Stockholm (Karolinska Institutet) and written informed consent was
obtained from all participants after a detailed description of the
study had been given.
To be eligible for inclusion potential participants had to meet
the following criteria: (a) fulfill the DSM-IV [25] criteria of social
anxiety disorder as assessed using the Structured Clinical Interview
for DSM-IV axis I disorders (SCID-I) [26], (b) agree to undergo no
other psychological treatment for the duration of the study, (c)
have no history of CBT for the last four years, (d) have constant
dosage two months prior to treatment of any prescribed
medication for anxiety or depression and agree to keep dosage
constant throughout the study, (e) have a primary diagnosis of
SAD as assessed by the interviewing psychiatrist (individuals with
comorbid disorders according to the Mini International Neuro-
psychiatric Interview (MINI) [27] were not excluded), (f) not
currently meet the diagnostic criteria for substance abuse (g) have
no history of psychosis or bipolar disorder, (h) not score .20 on
the Montgomery A ˚sberg Depression Rating Scale-self report
(MADRS-S) [28], (j) if criteria for major depression were met,
have a score of less than 4 of 6 on the suicide ideation item of
MADRS-S, and (k) not meet criteria for any personality disorders
within cluster A (e.g. paranoid personality disorder) or B (e.g.
antisocial personality disorder), which could interfere with the
therapeutic process in group therapy.
During the first stage of the recruitment process, potential
participants were asked to complete the Social Phobia Screening
Questionnaire (SPSQ) [29], MADRS-S, the Alcohol Use Disor-
ders Identification Test (AUDIT) [30], and the Drug User
Disorders Identification Test (DUDIT) [31]. In the second stage,
participants were invited to attend an interview with a psychiatrist
at the Karolinska University Hospital to confirm the SAD
diagnosis and establish whether they met the remaining inclusion
criteria (b-k). The psychiatrists conducting the assessments had
more than 10 years of experience working with structured
diagnostic interviews and had undergone extensive training in
the use of the primary outcome measure, as well as of the SCID
and the MINI. Two hundred thirty applicants completed the
screening questionnaires and underwent the interview. Of those,
126 met all 10 inclusion criteria. Figure 1 shows the participant
flow throughout the trial. Demographic information for partici-
pants is presented in Table 1.
Outcome measures
Social anxiety. The primary outcome measure was the
clinician administrated Liebowitz Social Anxiety Scale (LSAS)
[32,33]. The LSAS has good psychometric properties including
high internal consistency (Cronbach’s a=.96) and high test-retest
reliability over one week (r=.97) [32,34]. The self-report version
of LSAS (LSAS-SR) [35] was used as a complement during the
treatment phase The LSAS-SR has a high internal consistency
(Cronbach’s a=.95) as well as a high 12-week test-retest reliability
(r =.83) [32,35]. The Social Phobia Scale (SPS) [36] and the
Social Interaction Anxiety Scale (SIAS) [36] were also
administered to assess a broader spectrum of social anxiety
symptoms. Both scales have good psychometric properties [36].
General anxiety, anxiety sensitivity, depression and
quality of life. The Beck Anxiety Inventory (BAI) [37] and
the Anxiety Sensitivity Index (ASI) [38] were used to assess general
anxiety and anxiety sensitivity. The Montgomery A ˚sberg
Depression Rating Scale-self report (MADRS-S) [28] was used
to measure depressive symptoms. Finally, the Quality of Life
Inventory (QOLI) [39] was used to assess quality of life. The BAI,
ASI, MADRS-S and the QOLI have all demonstrated good
psychometric properties.
Diagnostic assessment, global functioning and
improvement. Psychiatric diagnoses were established using
the SCID-I-Research version (RV) [26], the SCID-II [40], and
the MINI [27]. The SCID-I-RV was used to assess SAD since it
has the advantage of providing information in greater detail than
the MINI (which was not used to assess criteria for SAD) and has
high inter-rater reliability [41]. To assess avoidant personality
disorder, we used SCID-II, which has very good inter-rater
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therapy; CBGT, Cognitive behavioral group therapy; SAD, Social anxiety disorder; Received, completed at least 5 modules (ICBT) or 5 sessions (CBGT).
doi:10.1371/journal.pone.0018001.g001
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than SAD [27]. Assessors used the Global Assessment of
Functioning Scale (GAF) [25] to measure global functioning and
the Clinical Global Impression Improvement Scale (CGI-I) [43] to
measure global improvement.
Assessment of treatment credibility and treatment
preference. A treatment credibility scale comprising five items
was administered to determine whether participants viewed the
two treatments as equally credible [44]. Prior to randomization
participants were asked to state their treatment preference (ICBT
or CBGT).
Administration format of self-report measures
We used an Internet application to administer the LSAS-SR,
SIAS, SPS, BAI, MADRS-S, and the QOLI. Internet and paper-
and-pencil administrations of these measures have been shown to
possess equivalent psychometric properties [45].
Procedure
Assessment points and randomization. Assessments,
including diagnostic interviews, were conducted before treatment
(i.e., pre-treatment), immediately after treatment (i.e., post-
treatment), and six months after treatment (i.e., follow-up).
During treatment, the LSAS-SR and the suicide ideation item of
MADRS-S were administered on a weekly basis. Participants
assessed treatment credibility after one week of treatment. The
randomization procedure involved two external persons not
involved in the study; one provided randomization data and the
other monitored that no manipulation of treatment allocation was
performed by the research group. A true random number service
(http://www.random.org) was used to ensure randomization. The
random sequence was generated after inclusion of participants to
ensure that assignment of intervention was concealed from
assessing psychiatrists and researchers of the study. Participants
were allocated to CBGT or ICBT in a 1:1 ratio using simple
randomization with no restrictions or matching. To ensure the
integrity of the blinding procedure, participants were instructed
not to mention which treatment they had received during the post-
treatment and follow-up interviews. After completing the
interviews, the assessing psychiatrists guessed allocation status for
each participant.
Monitoring of treatment integrity. Treatment integrity of
CBGT was ensured in three ways. First, we used a detailed
treatment manual [46]. Second, group therapists received
supervision throughout the trial by a licensed psychotherapist
specialized in CBT for SAD. Third, all sessions were audio
recorded and a random sample of 5 sessions was audited by a
clinical psychologist with more than 10 years of experience in
treating SAD with CBT. Using the Therapist Adherence Scale
(TAS) developed by the originators of CBGT [47], all reviewed
sessions were judged to have been conducted in accordance with
the treatment manual. The average TAS score of the reviewed
session was 4.5 (SD=0.5) on a 1 (ineffective) to 5 (extremely
effective) scale. Due to the fixed nature of ICBT and the limited
role of the therapist, no measure of treatment integrity was taken
for ICBT. However, all therapists who provided the guidance of
ICBT received supervision from a clinical psychologist throughout
the trial and all therapists had previous experience of that
treatment format.
Treatments
Internet-based cognitive behavior therapy (ICBT). The
ICBT employed in this study was based on the treatment
developed by Andersson and coworkers, and has been validated
by several randomized controlled trials [13,14,15]. The treatment
followed a CBT-model, developed for individual therapy, that
Table 1. Demographic description of the participants.
Variable ICBT CBGT
n=64 n=62
Gender Women (%) 24.0 (37.5) 21.0 (33.8)
Men (%) 40.0 (62.5) 41.0 (66.1)
Age Mean age (SD) 35.2 (11.1) 35.5 (11.6)
Min-max 20.1–63.2 18.0–64.1
Social anxiety disorder Generalized subtype (%) 56.0 (87.5) 53.0 (85.5)
Mean duration, years (median) 20 (18) 21.95 (21.5)
Mean age of onset 15.6 13.1
Occupational status Working 75–100 % (%) 51 (79.7) 42 (67.7)
Sick leave, part or full time (%) 4 (6.3) 6 (9.7)
Disability pension (%) 2 (3.2) 1 (1.6)
Referral From out patient clinics 16 (25) 13 (21.0)
Self-referral 48 (75) 49 (79)
Stabilized psychotropic medication SSRIs 14 11
SNRIs 2 4
Comorbid psychiatric disorders Any anxiety disorder 10 12
Major depression 10 9
Avoidant personality disorder 33 29
Abbreviations: ICBT, Internet-based Cognitive Behavior Therapy; CBGT, Cognitive Behavior Group Therapy; SSRI, Selective serotonin reuptake inhibitor; SNRI, Serotonin–
norepinephrine reuptake inhibitor.
doi:10.1371/journal.pone.0018001.t001
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as misinterpretations of social events and internal focus as
maintaining factors of SAD [48]. A vital part of the treatment
was the gradual access to internet-based self-help text comprising
15 text modules, each covering a specific theme (e.g., exposure or
cognitive restructuring) completed with a homework component.
The modules provided the participants with the same knowledge
and tools as conventional individual CBT for SAD.
The duration of ICBT was 15 weeks and throughout this period
the patient had access to a therapist via an online secure messaging
system. The role of the therapist was mainly to provide feedback
regarding home work and to grant access to the treatment
modules. However, the patient could contact the therapist at any
time and expect a reply within 24 hours during week days.
Patients and therapists had no face-to-face or telephone contact
during the treatment. The general instruction to the internet
therapists was to have the ambition to restrict time spent on each
patient to less than 10 minutes per week. This time frame was
judged possible as most messages to patients are very brief
entailing the core feed-back that the homework was successfully
completed and the next treatment module is accessible. The
therapists conducting ICBT were eight psychologists with one to
four years of experience in delivering CBT via the internet.
Cognitive behavioral group therapy (CBGT). This
treatment comprised an initial individual session followed by 14
group sessions over 15 weeks. The individual session prepared the
participant to begin group treatment sessions and included a
rationale for group treatment. Each group session was 2.5 hours
long, including a 15 minute break. Groups were lead by two
therapists and had six to seven participants. The CBGT followed
the protocol developed by Heimberg and Becker [46] with the
addition of two group sessions. The first two group sessions (i.e.,
Sessions 2–3) were aimed at teaching participants the role and
components of anxiety and how to identify and challenge negative
automatic thoughts. Sessions 4–14 focused primarily on
individually tailored in-session exposure in combination with
cognitive restructuring. Prior to exposure exercises, participants
identified and disputed negative automatic thoughts, developed
rational alternatives, and behavioral goals were set. Following the
exposure exercises, additional cognitive restructuring was
conducted and goal attainment was reviewed. Participants were
also given homework to continue exposure exercises in the same
fashion in their home environment. Session 14–15 were devoted to
assessing the progress of the participant and setting goals for the
future. A detailed plan was created for each participant to ensure
that goals and methods to achieve them were clear. The therapists
facilitating the CBGT sessions were six clinical psychologists with
2 to15 years experience in treating patients with SAD using CBT.
Statistical analysis
Statistical analyses were conducted using PASW version 18.0
(SPSS inc., Chicago). The non-inferiority margin of the primary
outcome measure LSAS was set at D10 points, which was based on
clinical judgment and a review of the evidence of CBGT
compared to credible control conditions for SAD. Meta-analytic
reviews, adopting random-effects models, have estimated the lower
bound of the 95% confidence interval (CI) of the between group
effect size to 0.39 (Hedges’g) [49]. Assuming a standard variance of
LSAS scores in our sample, this supported the use of 10 LSAS
points as a non-inferiority margin. Test criterion for non-
inferiority was that the lower bound of the 95% CI of the mean
difference should fall within D. With 95% probability, the mean
difference between ICBT and CGBT had to be smaller than 10
LSAS points. As this was a non-inferiority trial, this criterion did
not apply for the upper bound of the CI, meaning that the CI
could exceed 10 LSAS points if in favor of ICBT. For the other
continuous measures, the non-inferiority margin was set at D
Cohen’s d=0.5. Test criterion for non-inferiority for these
measures was that the lower bound of the 95% CI of between
group effect sizes should fall within this range. This criterion was
judged acceptable as it has been proposed that an effect size of 0.5
marks the border between a mild and moderate effect [50]. Thus,
this criterion meant that mild effects up to the border of moderate
effects were acceptable.
Main outcome continuous variables were analyzed using a
linear mixed effects model because of its superior qualities
regarding missing data as well as in reducing the risk of
committing type I errors [51]. We employed the restricted
maximum likelihood method assuming a compound symmetry
model as covariance structure since it provided the best model in
an information criteria comparison. T-tests were used to compare
treatment credibility ratings and x
2 tests to assess nominal scale
variables. Wilcoxon tests and Mann-Whitney U tests were used to
analyze outcomes on ordinal scale variables. To estimate rates of
responders, we used the clinical significant improvement criteria as
suggested by Jacobson and Truax on the primary outcome
measure [52]. The criteria for clinical significant improvement was
to have a score below 43.3 (closer to healthy population than to
SAD population [53] and the reliable change criterion was
established using the test-retest reliability coefficient of .97 [34].
Cohen’s d based on pooled standard deviations was used to
calculate effect sizes. The sample size was considered satisfactory
since power calculations showed that there was a chance slightly
lower than 80% to detect a difference, given the non-inferiority
criteria used and an alpha-level of .05. The main analyses were
conducted in accordance to intention-to-treat principle, i.e. all
available assessment data was analyzed in accordance to how
participants were randomized. This meant that participants were
encouraged to provide assessment data regardless of treatment
adherence. On the CGI-I scale, missing values were replaced with
‘‘no change’’. As a complement, the social anxiety measures were
also analyzed based on the sample of completers only. There were
no significant differences between the groups on the outcome
measures at baseline (t (1, 124)=0.02–1.38, p=.17–.98).
Results
Attrition
Loss of data is presented in Figure 1.
Effect sizes and non-inferiority
Within group effect sizes on the primary outcome measure
LSAS were large for both treatments. At post-treatment and six
month follow-up respectively, the 95 % CI of the mean difference
between the groups on LSAS score was 0.68–17.66 and 22.5–
15.69, favoring ICBT. This was well within the non-inferiority
margin of 10 LSAS points for the lower bound. Analysis of the
other continuous measures showed that all lower bounds of 95%
CIs for between group effect sizes fell well within the non-
inferiority margin of d=0.5 effect sizes. As stated above, Table 2
provides within and between group effect sizes on continuous
outcome measures.
Treatment effectiveness - primary outcome measure
(LSAS)
At post-treatment, 35 (55%) of the participants (95% CI,
42.5%–66.9%) in the ICBT group were classified as responders
according to the Jacobson and Truax criteria [52] compared to 21
Internet-Based CBT vs. Group CBT for SAD - A RCT
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At six-month follow-up, the corresponding number was 41 (64%)
in the ICBT group (95% CI, 52.3%–75.8%) and 28 (45%) in the
CBGT group (95% CI, 32.8%–57.6%). Mixed effects model
analysis showed a significant effect of time, indicating improve-
ment in both treatment groups (F=179.06; df=1,219; p,.001).
There was no significant interaction of group and time for the
primary outcome measure LSAS, indicating similar improvement
across groups (F=1.58; df=2, 219; p=.21). As illustrated in
Figure 2, there were continuous within group improvements
throughout the trial on the LSAS-SR in both conditions. The
means (SDs) on the LSAS-SR at pre, post and follow-up
respectively were 65.0 (23.6), 41.1 (21.5), 38.7 (23.1) for the ICBT
group and 73.9 (21.5), 52.2 (25.5), 50.0 (24.9) for the CBGT
group. There was no significant interaction of group and time for
the LSAS-SR (F=0.25; df=2, 243; p=.77). Table 2 provides
within and between group effect sizes on measures of social
anxiety, depression, general anxiety, quality of life and anxiety
sensitivity.
Treatment effectiveness - secondary outcome measures
Social anxiety. There was a significant effect of time on both
the SIAS and SPS (F=80.95 283.39; df=2,p,.001).Mixed effects
model analysis showed no significant interaction of group and time
for these variables (F=0.30–0.48; df=2, 244; p=.62–.74).
Depression, general anxiety, anxiety sensitivity and
quality of life. There was a significant effect of time on
MADRS-S, BAI, ASI and QOLI (F=17.26–52.30; df=2, 227–
245; p,.001). Analysis using mixed effects model yielded no
significant interaction of group and time for these variables
(F=0.26–1.30; df=2, 227–245; p=.28–.77).
Clinician administrated measures of global improvement
and functioning. At post-treatment, 42 participants (66%) in
the ICBT group were classified as very much improved or much
improved according to the CGI-I (95% CI, 59.1%–81.5%). In
the CBGT group, the corresponding number of participants was
34 (55%) as assessed using the CGI-I (95% CI, 42.5%–67.2%).
Wilcoxon tests showed that participants who had received ICBT
were further improved at follow-up according to the CGI-I
(Z=2.33, p,.02), but CBGT participants were not (Z=1.50,
p=.14). Mann-Whitney U-test showed no significant difference
between ICBT and CGBT at post-treatment (p=.08.). However,
at six-month follow-up, participants receiving ICBT were
significantly more improved on the CGI-I (p,.01). Figure 3
displays CGI-I scores at post-treatment and follow-up. The
means (SDs) on the GAF at pre, post and follow-up respectively
were 57.3 (9.8), 66.8 (10.0), 70.4 (11.3) for the CBGT group and
59.5 (6.4), 69.7 (10.8), 74.5 (11.6) for the ICBT group. Using a
mixed effects model approach, no significant interaction of time
and treatment group was found on the GAF (F=0.354; df=2,
225; p=.59).
Psychiatric diagnosis at each assessment point.
Following treatment, 18 (31 %) participants who had received
ICBT no longer met diagnostic criteria for SAD (28 % if
Table 2. Means, SDs and effect sizes (Cohen’s d) for measures of social anxiety and secondary outcome variables.
Effect size Effect size Effect size Effect size
Measure Group Pre Post FU Between Between Whithin Within
M (SD) M (SD) M (SD) Post (95% CI) Follow-up (95% CI) Pre-Post Pre-FU
LSAS ICBT 68.4 (21.0) 39.4 (19.9) 32.1 (23.1) 1.42 1.64
0.41 (0.03–0.78) 0.36 (20.02–0.75)
CBGT 71.9 (22.9) 48.5 (25.0) 40.7 (23.7) 0.97 1.34
SIAS ICBT 46.2 (16.8) 34.6 (15.1) 29.9 (15.7) 0.73 1.01
0.24 (20.11–0.59) 0.33 (20.03–0.69)
CBGT 49.3 (14.8) 38.53 (15.7) 34.6 (15.1) 0.72 0.93
SPS ICBT 32.8 (14.6) 21.6 (13.5) 17.6 (13.9) 0.80 1.06
0.04 (20.31–0.39) 0.16 (20.20–0.51)
CBGT 33.5 (14.0) 22.1 (14.3) 19.7 (13.6) 0.80 0.99
MADRS-S ICBT 12.7 (6.5) 9.1 (6.9) 8.8 (8.3) 0.53 0.52
0.29 (20.06–0.64) 0.21 (20.15–0.57)
CBGT 14.0 (8.0) 11.5 (8.8) 10.5 (8.6) 0.30 0.41
BAI ICBT 18.7 (10.9) 12.1 (8.6) 10.6 (10.0) 0.67 0.77
0.21 (20.14–0.56) 0.13 (223–0.48)
CBGT 18.6 (10.8) 14.2 (11.3) 11.8 (9.2) 0.40 0.77
QOLI ICBT 0.8 (1.5) 1.6 (1.6) 1.8 (1.5) 0.51 0.69
0.27 (20.08–0.62) 0.46 (0.10–0.82)
CBGT 0.4 (1.6) 1.1 (1.7) 1.1 (1.5) 0.45 0.47
ASI ICBT 22.6 (11.0) 16.1 (10.8) 14.4 (11.3) 0.59 0.73
0.14 (20.21–0.49) 20.11 (20.44–0.27)
CBGT 22.0 (10.0) 17.6 (10.7) 13.6 (8.7) 0.42 0.89
Abbreviations: ICBT, Internet-based Cognitive Behavior Therapy; CBGT, Cognitive Behavior Group Therapy; Pre, before treatment; Post, post-treatment; FU, six months
after treatment; LSAS, Liebowitz Social Anxiety Scale; SIAS, Social Interaction Scale; SPS, Social Phobia Scale; MADRS-S, Montgomery-A ˚sberg Depression Rating Scale-Self
report; BAI, Beck Anxiety Inventory; QOLI, Quality of Life Inventory; ASI, Anxiety Sensitivity Index.
doi:10.1371/journal.pone.0018001.t002
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number for participants who underwent CBGT was 12 (23 %;
19 % if considering dropouts non-responders). At follow-up, 25
(46%) participants who had received ICBT (41% if considering
dropouts non-responders) and 21 (40%) receiving CBGT (34% if
considering dropouts non-responders) no longer met diagnostic
criteria for SAD. At post-treatment and six month follow-up there
was no significant difference in the prevalence of SAD between
groups (x
2=037–1.33, df=1, p=.25–.55).
Treatment credibility
Credibility ratings after one week of treatment showed that
participants in both groups rated their respective treatment as
credible. Out of a possible total of 50, the average scores were 34.0
Figure 2. Weekly change on LSAS-SR during treatment and LSAS scores at each assessment point. Abbreviations: ICBT, Internet-based
cognitive behavior therapy; CBGT, Cognitive behavioral group therapy; LSAS, Liebowitz Social Anxiety Scale; -SR, Self-report; CA, Clinician
administered; Pre, Before treatment; Post, Post-treatment; 6MFU, Six months after treatment.
doi:10.1371/journal.pone.0018001.g002
Figure 3. CGI-I scores at post-treatment and six-month follow-up. Abbreviations: ICBT, Internet-based cognitive behavior therapy; CBGT,
Cognitive behavioral group therapy; CGI-I, Clinical Global Impression Improvement Scale.
doi:10.1371/journal.pone.0018001.g003
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tively. There was no significant difference in treatment credibility
between treatment groups (t (1, 110)=0.07, p=.95).
Assessment of blinding and treatment preference
In four instances the blinding was broken. On two occasions
participants accidentally mentioned their treatment allocation
status to the assessor, and in other two occasions it was deemed
necessary to break the blinding because of the need to assess
increased depressive symptoms during treatment. As shown in
Table 3, there was no significant association between assessors’
guess and actual treatment allocation (x
2=0.27, df=1, p=.61),
indicating successful blinding.
Prior to randomization participants were asked to state their
treatment preference. Of 126 participants, 68 (54%) preferred
ICBT and 58 (46%) CBGT. There was no difference between
groups in terms of proportion of participants that received the
preferred treatment (x
2=0.77, df=1, p=.38).
Treatment adherence
In CBGT, the average number of attended sessions per
participant was 9.40 (SD=4.87) out of a possible total of 15.
Fifty participants in CBGT (81%) attended at least five sessions
and 17 (27%) attended all sessions. The average number of
completed modules in ICBT was 9.33 (SD=4.95) of 15. Fifty-
one participants in ICBT (80%) completed at least 5 modules
and 19 (29.7%) completed all modules. Important to note is that
the main components of the treatments had been introduced at
week 5.
Evaluation of therapist resources required for each
treatment
On average, therapists delivering ICBT spent 5.5 minutes
(SD=3.6) weekly per patient. The corresponding amount of time
in CBGT was 50 minutes (2.5 h sessions with two therapists and 6
patients). Taking nonattendance into consideration, this number
would have been even higher. ICBT therapists sent 17.4 messages
to each patient on average, i.e. 1.2 weekly per patient.
Intention-to-treat vs. treatment exposed analysis
Analysis including only those exposed to treatment (at least five
sessions or modules) yielded results equal to the intention-to-treat
analysis on continuous outcome measures of social anxiety,
indicating that between group effects in the latter were not
moderated by completion status. There was a significant effect of
time on all three measures (F=90.52 -188.67; df=2, 188–198;
p,.001). Mixed effects models analysis showed no significant
interaction effect of time and treatment group on the LSAS
(F=1.78; df=2, 188; p=.17), nor on the SIAS and the SPS
(F=0.32–0.43; df=2, 198; p=.66–.73).
Discussion
The present study is the first to demonstrate that ICBT can be
as effective as CBGT in the treatment of SAD. Both treatments
demonstrated large within group effect sizes on measures of social
anxiety and general anxiety. The confidence interval of mean
differences of the primary outcome measure fell well within the
non-inferiority margin and between-group effect sizes were small
but consistently favoring ICBT on the social anxiety measures.
There was also a large proportion of participants who were
classified as much improved or very much improved at post-
treatment and follow-up in both treatment groups. The indication
that the ICBT group was slightly more improved on the CGI-I
should be interpreted cautiously as effects were small and no
alpha-level corrections were set. The follow-up assessment
indicated that treatment gains were sustained on all measures.
These results indicate that ICBT can be an effective treatment for
patients with SAD when delivered in a regular psychiatric setting.
In trials assessing non-inferiority it is essential that the effect of
the gold standard treatment is as effective as in previous trials. This
was the case in the present study, where CBGT yielded effects in
line with trials conducted by its originators [54]. Moreover,
treatment effects for ICBT were equivalent to those reported in
previous controlled trials [13,14,15,17,18]. These are strengths of
the present study. As reduced therapist time is an important
element of ICBT, a key finding in this study is that ICBT reduced
therapist time per treated patient by 90% compared to CBGT. As
previously stated, individual CBT developed by Clark and Wells
(1995) may be even more effective than CBGT. It could therefore
be argued that Clark’s individual cognitive therapy should be the
benchmark against which ICBT is contrasted. However, as CBGT
has been evaluated in more trials and is more established, we
decided to use CBGT as the benchmark treatment.
Overall, we interpret the results of the present study as
indicating that a substantial proportion of persons with SAD
respond well to ICBT. However, for those who do not respond to
ICBT, an intensified treatment such as individual face-to-face
CBT might be superior. Thus, we view ICBT as a complement
(not a substitute) to conventional CBT that could facilitate the
dissemination of CBT and improve healthcare resource allocation.
When results are interpreted it is also important to bear in mind
that that the non-inferiority margin allowed for up to a moderate
effect between treatments. However, this margin was judged as
clinically valid, and again, if ICBT is to be used as a complement,
the usefulness of employing very narrow non-inferiority margins is
limited.
There are several limitations that warrant mention and could
provide venues for future research. First, there was no random-
ization to an active placebo condition, which raises the issue of
misinterpreting regression to the mean as indicative of two
effective treatments. However, given the chronicity demonstrated
by SAD [55], high proportions of spontaneous remission is
improbable. In addition, meta-analytic evidence suggests CBT for
anxiety disorders tends to be more effective than placebo [49]. A
second limitation concerns patient preferences. It is likely that
participants in our trial were willing to receive either ICBT or
CBGT, which may not be representative for persons with SAD in
the general population. It may be that internet treatment is
preferred over group treatment. Despite the observation that
persons with SAD are frequent internet users [56], this has not yet
been studied. Third, the current study did not include long-term
Table 3. Agreement between actual treatment status and
assessors’ guess (expected frequency).
Assignment Assessors’ guess
ICBT CBGT Total
ICBT 38 (36.6) 26 (27.4) 64
CBGT 34 (35.4) 28 (26.6) 62
Total 72 54 126
Abbreviations: ICBT, Internet-based Cognitive Behavior Therapy; CBGT,
Cognitive Behavior Group Therapy.
doi:10.1371/journal.pone.0018001.t003
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CBGT and ICBTs protocol for SAD are enduring over durations
longer than six months. However, previous studies of CBGT [57]
and ICBT suggest that the results may be enduring [19]. The
adherence rate also deserves mentioning. Eighty percent of the
participants completed at least the first five weeks of therapy and
were thereby exposed to the main components of the treatment,
although significantly fewer completed all sessions or modules.
Still, we find that having completed five weeks is an important
threshold as preliminary analyses of outcome predictors have
shown that completing at least five weeks is associated with better
outcome, whereas completing all sessions or modules seems to
yield little additional effect. As for CBGT, this adherence rate is
comparable to that of a recently conducted large scale RCT where
35% of CBGT participants discontinued treatment [58]. Finally,
we did not assess treatment satisfaction in the present study.
However, data from regular care of the Internet clinic where this
study was conducted suggest high satisfaction with treatment as the
average score on the Client Satisfaction Questionnaire [59] is 3.18
(SD=0.57) using a scale range of 1–4.
In spite of these limitations, we conclude that ICBT may be at
least as effective as CBGT, and that it is feasible to conduct ICBT
for SAD in a psychiatric setting. As ICBT requires much less
resources than conventional CBT, it could be the most promising
means to increase the availability of CBT for persons affected by
SAD.
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